We need to boost access to anti-obesity medications in Delaware — not limit it

Peggy Geisler
·3 min read

Obesity is one of America’s most pressing health epidemics, yet it has been consistently overlooked by policymakers. We have been aware of this crisis since 1999, when the Centers for Disease Control and Prevention declared obesity to be a public health epidemic. Yet a quarter of a century later, we have seen very limited success in mitigating this pressing issue. While some leaders such as Sen. Tom Carper have taken a proactive stance against the obesity epidemic, multiple administrations have not done enough. Unfortunately, the epidemic has fallen hardest on communities of color which are already struggling with poverty and other health-related problems. Put simply, obesity has become a death spiral in which health complications lead to a rise in chronic disease, which leads to an increased strain on our nation’s healthcare system. As one would imagine, this leads to higher costs for all of us.

Obesity has a litany of comorbidities that present a daunting challenge for both patients and healthcare providers. These include heart disease, heart attacks, diabetes, stroke and kidney disease. In 2022, a study conducted by the National Institute on Aging showed that the prevalence of obesity among seniors has doubled since the 1990s. The obesity epidemic afflicts every cohort, but African American, Hispanic and Native American communities have borne the brunt the hardest. All in all, it’s estimated that obesity related illnesses can claim the lives of up to over 300,000 Americans annually.

It's also estimated that spending on obesity related healthcare incurs costs of $1.72 trillion, which represents 9.3% of our economy. Due to the economic burden obesity related illnesses cause, low-income Americans often lack the resources to effectively manage their healthcare. It has become a reality that access to effective treatment is out of reach for an alarming number of patients.

Yet, it doesn’t have to be this way. Recent studies have shown that something as simple as improved access to medications can have dramatic effects for those suffering with obesity. One recent study has shown that certain AOMs (anti-obesity medications) can reduce the risk of cardiovascular diseases linked to obesity by up to 20%. The University of California Schaeffer Center for Health Policy and Economics has projected that expanding access to AOMs is estimated to have an offset worth $175 billion in Medicare spending within the first decade. Expanding access to AOMs through Medicare Part D is a simple solution that could save millions of lives and trillions in spending over the course of a few decades.

Expanding access to AOMs through Medicare Part D is a simple solution that could save millions of lives and trillions in spending over the course of a few decades.
Expanding access to AOMs through Medicare Part D is a simple solution that could save millions of lives and trillions in spending over the course of a few decades.

The Sussex County Health Coalition is an all-encompassing organization within the health sphere. As a result, we have seen the pernicious effects of the obesity epidemic at all levels of care. More equitable access to AOMs would have an extensive positive impact on the health of both Sussex County and Delaware at large. On a human level, AOMs can add years to life and life to years for those living with obesity — no one should be prohibited from enjoying the natural beauty of our Seashore region. On the economic side, the money saved through improved health outcomes will not only benefit Delaware's finances but also put more dollars into the local economy, stimulating small and family-owned businesses.

America now sits at a crossroads, and we need our leaders to take decisive action to help combat the obesity epidemic directly. Congressional leaders and the administration must work together to expand access to AOMs through Medicare Part D. This is the most efficient method to get these critical lifesaving drugs to those who need them the most. Not only is it the most cost-effective method of reducing overall healthcare spending but it is the moral and most efficacious action to take. If our current leaders stand aside and allow more Americans to continue to suffer from obesity, we risk digging ourselves into a deeper hole and further raising the cost of action on future generations.

Peggy Geisler is executive director of the Sussex County Health Coalition, which exists to engage the entire community in collaborative family-focused effort to improve the health of children, youth and families in Sussex County.

This article originally appeared on Delaware News Journal: Delaware needs broader access to anti-obesity medications